SG Americas Securities
CRL icon

SG Americas Securities’s Charles River Laboratories CRL Stock Holding History

SG Americas Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-49,000
Closed -$131K – 2975
2015
Q4 		$131K Buy
+49,000
New +$3.53M ﹤0.01% 2289

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SG Americas Securities's CRL Position: Q1 2026 in Review

SG Americas Securities increased its Charles River Laboratories (CRL) stake by 2.4% in Q1 2026, buying an estimated $815K and bringing the position to 186,173 shares worth $32.1M. The position accounts for 0.03% of the portfolio, ranked #392.

SG Americas Securities first reported a position in CRL in Q2 2013 and has held it in 49 quarters since. The position peaked at $40.2M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • SG Americas Securities held 186,173 shares of Charles River Laboratories worth $32.1M as of Q1 2026.
  • SG Americas Securities bought 4,395 Charles River Laboratories shares in Q1 2026, an estimated $815K.
  • Charles River Laboratories made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #392 holding.
  • SG Americas Securities first reported a position in Charles River Laboratories in Q2 2013 and has held it in 49 quarters since.
  • SG Americas Securities's Charles River Laboratories position peaked at $40.2M in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.